BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31194134)

  • 1. Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review.
    Belkhair J; Raissi A; Elyahyaoui H; Ameur MA; Chakour M
    Leuk Res Rep; 2019; 12():100172. PubMed ID: 31194134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare atypical chronic myeloid leukemia BCR-ABL1 negative with concomitant
    Gao T; Yu C; Xia S; Liang T; Gu X; Liu Z
    Ther Adv Hematol; 2020; 11():2040620720927105. PubMed ID: 32782768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BCR-ABL1 negative chronic myeloid leukemia: report of two cases].
    Figueroa-Faúndez F; Vidal-Rojas C; Briones-Muñoz V; Chandía-Cabas M
    Rev Med Chil; 2022 Mar; 150(3):397-401. PubMed ID: 36156725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
    Sadigh S; Hasserjian RP; Hobbs G
    Curr Opin Hematol; 2020 Mar; 27(2):122-127. PubMed ID: 31904665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
    Elsayed M; Harry S; Nanua S; Zaidi S; Habib MH; Raza S
    Cureus; 2022 Jul; 14(7):e26619. PubMed ID: 35949766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
    Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
    Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solving the Puzzle: The Diagnosis of Atypical Chronic Myeloid Leukemia, BCR-ABL1-Negative (aCML).
    Danyal K; Devitt K; Gardner JA
    J Assoc Genet Technol; 2021; 47(3):127-131. PubMed ID: 34491231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
    Castellino A; Santambrogio E; Rapezzi D; Massaia M
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
    Fend F; Horn T; Koch I; Vela T; Orazi A
    Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Management of Atypical Chronic Myeloid Leukemia with a t(2;13)(q33;q12) Translocation.
    Wang JS; Elghawy O; Kurpiel BR; Douvas MG
    Case Rep Hematol; 2022; 2022():4628183. PubMed ID: 35571528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical CML with TET2 mutation, associated with NRAS and KRAS: A case report and literature review.
    Abuzneid YS; Alzeerelhouseini HIA; Marzouqa N; Yaghi Y; Al-Ihribat AR; Alqam B; Krama A
    Ann Med Surg (Lond); 2021 Nov; 71():102980. PubMed ID: 34840744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical chronic myeloid leukaemia - a rare subtype of myelodysplastic/myeloproliferative neoplasm.
    Drozd-Sokołowska JE; Waszczuk-Gajda A; Mądry K; Dwilewicz-Trojaczek J
    Contemp Oncol (Pozn); 2018; 22(1):14-19. PubMed ID: 29692658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Chronic Myelogenous Leukemia,
    Diamantopoulos PT; Viniou NA
    Front Oncol; 2021; 11():722507. PubMed ID: 34868917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.
    Gurnari C; Panetta P; Fabiani E; Nardone AM; Postorivo D; Falconi G; Franceschini L; Rizzo M; Rapisarda VM; De Bellis E; Lo-Coco F; Voso MT
    Mol Clin Oncol; 2018 Mar; 8(3):463-465. PubMed ID: 29468060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH; Li H; Cai H
    Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia.
    Hernández JM; del Cañizo MC; Cuneo A; García JL; Gutiérrez NC; González M; Castoldi G; San Miguel JF
    Ann Oncol; 2000 Apr; 11(4):441-4. PubMed ID: 10847463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
    Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC; Mascarenhas J
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.